The North America Phenylketonuria Drug Market reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031. North America Phenylketonuria Drug Market By Applications Applications Segmentation:– Classic PKU– Moderate PKU– Maternal PKU– Non-PKU Hyperphenylalaninemia– Others The… Continue reading North America Phenylketonuria Drug Market By Application